News

Writer-producer Donick Cary has spent his whole career near the top of the showbiz comedy heap, from stints on “Late Show with David Letterman” and “The Simpsons” to sitcoms like “Just Shoot Me!,” “New Girl,” “Parks and Recreation” and “Silicon Valley.” So it shouldn’t surprise that his first directorial feature, the documentary “Have a Good Trip,” is less a serious dive into its chosen subject than an excuse to have a lot of familiar-face colleagues and acquaintances serve up funny anecdotes.

Since those anecdotes are about hallucinogenic drug usage, this Netflix Original can hardly help but be entertaining. It also comes nicely kitted out with plentiful animation, campy archival snippets, comedy-sketch “reenactments” and more. But those looking for much in the way of real insight will find this amiable enterprise doesn’t stray very far from a general, standard-stoner-yuks tenor of “Omg I was So High!!!”

At least there’s little pretense otherwise,...

For the first time in U.S. history, a psychedelic drug is on the fast track to getting approved for treating depression by the federal government. Late last month, Compass Therapeutics, a U.K.-based company that researches and develops mental health treatments, announced the Fda granted them what’s called a “breakthrough therapy designation” for their trials into psilocybin, the psychoactive ingredient in psychedelic mushrooms.

Researchers who pioneered psychedelic science agree — this is a landmark moment for their field.

“It really does represent a significant development in the whole history of psychedelic research,...

New research shows that Mdma, the chemical compound found in the street drug ecstasy, may help adults with autism cope with the social anxiety often associated with the disorder.

Charles Grob, M.D., and Alicia Danforth, Ph.D., researchers at the Los Angeles Biomedical Research Institute at Harbor-ucla Medical Center, gave either Mdma or a placebo to 12 participants with autism in this small pilot study, during two eight-hour psychotherapy sessions. They used the Liebowitz Social Anxiety Scale (Lsas) to measure participants’ anxiety levels before the treatment, and one month after the second session.